As Flexion Therapeutics (FLXN) Stock Price Declined, Gagnon Securities Raised Stake by $4.86 Million; Universal Health Services Cl B (UHS) Stock Price Rose While Loomis Sayles & Company LP Has Decreased Holding by $372,109

April 17, 2018 - By Henry Gaston

Universal Health Services, Inc. (NYSE:UHS) Logo

Gagnon Securities Llc increased its stake in Flexion Therapeutics Inc (FLXN) by 134.6% based on its latest 2017Q4 regulatory filing with the SEC. Gagnon Securities Llc bought 194,276 shares as the company’s stock declined 8.56% with the market. The institutional investor held 338,607 shares of the health care company at the end of 2017Q4, valued at $8.48 million, up from 144,331 at the end of the previous reported quarter. Gagnon Securities Llc who had been investing in Flexion Therapeutics Inc for a number of months, seems to be bullish on the $1.00B market cap company. The stock increased 5.16% or $1.31 during the last trading session, reaching $26.69. About 596,379 shares traded. Flexion Therapeutics, Inc. (NASDAQ:FLXN) has declined 21.46% since April 17, 2017 and is downtrending. It has underperformed by 33.01% the S&P500.

Loomis Sayles & Company LP decreased its stake in Universal Health Services Cl B (UHS) by 5.97% based on its latest 2017Q4 regulatory filing with the SEC. Loomis Sayles & Company LP sold 3,293 shares as the company’s stock rose 4.68% while stock markets declined. The institutional investor held 51,869 shares of the health care company at the end of 2017Q4, valued at $5.88 million, down from 55,162 at the end of the previous reported quarter. Loomis Sayles & Company LP who had been investing in Universal Health Services Cl B for a number of months, seems to be less bullish one the $11.36B market cap company. The stock increased 0.13% or $0.16 during the last trading session, reaching $120.71. About 433,297 shares traded. Universal Health Services, Inc. (NYSE:UHS) has declined 4.39% since April 17, 2017 and is downtrending. It has underperformed by 15.94% the S&P500.

Investors sentiment increased to 3.07 in 2017 Q4. Its up 1.85, from 1.22 in 2017Q3. It increased, as 10 investors sold FLXN shares while 18 reduced holdings. 31 funds opened positions while 55 raised stakes. 67.26 million shares or 158.63% more from 26.01 million shares in 2017Q3 were reported. Fmr Ltd Llc stated it has 243,300 shares. California State Teachers Retirement Systems owns 51,660 shares. American Grp Inc holds 0% of its portfolio in Flexion Therapeutics, Inc. (NASDAQ:FLXN) for 22,076 shares. State Of Wisconsin Board invested in 0% or 21,000 shares. Gsa Prtnrs Limited Liability Partnership reported 0.1% stake. Dupont Mngmt Corporation holds 0.02% in Flexion Therapeutics, Inc. (NASDAQ:FLXN) or 27,334 shares. Deutsche Commercial Bank Ag holds 0% or 77,270 shares in its portfolio. Wasatch Incorporated has 0.22% invested in Flexion Therapeutics, Inc. (NASDAQ:FLXN). Scholtz & Limited Co reported 86,375 shares. Moreover, Ionic Mgmt Limited Liability has 0.21% invested in Flexion Therapeutics, Inc. (NASDAQ:FLXN). Virginia Retirement System Et Al, a Virginia-based fund reported 11,300 shares. Jpmorgan Chase owns 166,171 shares for 0% of their portfolio. Barclays Public Ltd Com stated it has 0% in Flexion Therapeutics, Inc. (NASDAQ:FLXN). The Illinois-based Northern has invested 0% in Flexion Therapeutics, Inc. (NASDAQ:FLXN). Css Limited Liability Il stated it has 0.01% in Flexion Therapeutics, Inc. (NASDAQ:FLXN).

Among 10 analysts covering Flexion Therapeutics (NASDAQ:FLXN), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Flexion Therapeutics had 24 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Flexion Therapeutics, Inc. (NASDAQ:FLXN) has “Buy” rating given on Wednesday, October 4 by Northland Capital. The stock has “Buy” rating by Lake Street on Thursday, July 21. The firm earned “Buy” rating on Monday, June 26 by BMO Capital Markets. Wells Fargo maintained it with “Buy” rating and $39.0 target in Monday, October 30 report. The stock has “Buy” rating by RBC Capital Markets on Tuesday, October 24. The firm earned “Outperform” rating on Wednesday, June 29 by BMO Capital Markets. The stock of Flexion Therapeutics, Inc. (NASDAQ:FLXN) has “Buy” rating given on Tuesday, April 3 by Wells Fargo. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, June 12 report. The stock has “Buy” rating by Needham on Wednesday, September 9. As per Monday, October 9, the company rating was maintained by BMO Capital Markets.

Gagnon Securities Llc, which manages about $353.18 million and $281.80M US Long portfolio, decreased its stake in Caredx Inc (NASDAQ:CDNA) by 287,657 shares to 1.88M shares, valued at $13.79M in 2017Q4, according to the filing. It also reduced its holding in Zogenix Inc by 65,305 shares in the quarter, leaving it with 38,460 shares, and cut its stake in General Electric Co (NYSE:GE).

Loomis Sayles & Company L P, which manages about $48.05 billion US Long portfolio, upped its stake in Ilg Inc by 17,063 shares to 810,781 shares, valued at $23.09M in 2017Q4, according to the filing. It also increased its holding in Danaher Corp (NYSE:DHR) by 73,090 shares in the quarter, for a total of 898,487 shares, and has risen its stake in Wabtec Corp (NYSE:WAB).

Investors sentiment increased to 1.05 in Q4 2017. Its up 0.15, from 0.9 in 2017Q3. It improved, as 44 investors sold UHS shares while 114 reduced holdings. 54 funds opened positions while 112 raised stakes. 80.04 million shares or 0.77% less from 80.67 million shares in 2017Q3 were reported. Old Second Bank Of Aurora holds 0.02% of its portfolio in Universal Health Services, Inc. (NYSE:UHS) for 450 shares. Fred Alger holds 115 shares or 0% of its portfolio. Connecticut-based Hartford Investment Mngmt Co has invested 0.05% in Universal Health Services, Inc. (NYSE:UHS). Point72 Asset Mgmt Lp has 0.18% invested in Universal Health Services, Inc. (NYSE:UHS). Whittier has 360 shares for 0% of their portfolio. Lazard Asset Mngmt Ltd Liability Company holds 0% or 4,730 shares. Mackenzie accumulated 23,782 shares. Hsbc Hldgs Public Ltd Co has invested 0.02% in Universal Health Services, Inc. (NYSE:UHS). Dean Inv Associates Ltd Limited Liability Company has 6,702 shares for 0.12% of their portfolio. Stratos Wealth Ptnrs Limited invested in 1,611 shares. Cap Impact Advsr Ltd Limited Liability Company holds 0.82% or 16,799 shares in its portfolio. Bessemer Gp reported 0% of its portfolio in Universal Health Services, Inc. (NYSE:UHS). Endurance Wealth Mgmt has invested 0% in Universal Health Services, Inc. (NYSE:UHS). Thrivent For Lutherans accumulated 520,891 shares or 0.2% of the stock. British Columbia Inv Mgmt Corp owns 0.01% invested in Universal Health Services, Inc. (NYSE:UHS) for 18,073 shares.

Among 23 analysts covering Universal Health Services Inc. (NYSE:UHS), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Universal Health Services Inc. had 63 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Universal Health Services, Inc. (NYSE:UHS) earned “Buy” rating by KeyBanc Capital Markets on Thursday, September 7. RBC Capital Markets maintained the shares of UHS in report on Tuesday, August 4 with “Outperform” rating. The stock of Universal Health Services, Inc. (NYSE:UHS) has “Mkt Perform” rating given on Wednesday, November 9 by Avondale. On Wednesday, December 16 the stock rating was initiated by Credit Suisse with “Neutral”. The rating was downgraded by PiperJaffray to “Neutral” on Wednesday, January 3. Stephens maintained it with “Hold” rating and $120.0 target in Thursday, March 1 report. The company was maintained on Friday, April 29 by RBC Capital Markets. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, August 27 report. Mizuho maintained it with “Buy” rating and $166 target in Friday, July 31 report. The firm has “Buy” rating given on Thursday, October 27 by Mizuho.

Analysts await Universal Health Services, Inc. (NYSE:UHS) to report earnings on April, 25 after the close. They expect $2.59 earnings per share, up 23.33% or $0.49 from last year’s $2.1 per share. UHS’s profit will be $243.77M for 11.65 P/E if the $2.59 EPS becomes a reality. After $2.00 actual earnings per share reported by Universal Health Services, Inc. for the previous quarter, Wall Street now forecasts 29.50% EPS growth.

Flexion Therapeutics, Inc. (NASDAQ:FLXN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: